Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Association of Treatment Regimens and Host Factors with PKDL
NCT01975051Phase 4Completed
- Sponsor
- icddr,b
- Start
- Jan 2013
- Primary completion
- Sep 2014
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of miltefosine in Post kala-azar dermal leishmaniasis (PKDL), sponsored by icddr,b. Started Jan 2013; status: completed.
02
Drugs
miltefosine
03
Conditions
Post kala-azar dermal leishmaniasis (PKDL)
Beyond the preview
Go deeper on NCT01975051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01975051.